Finally, knockdown of SS18-SSX in SS cell lines induced loss of differentiation abilities into mesenchymal-derived tissue, strongly supporting the hypothesis of a MSC origin for this tumor [30]. This evidence concerns the gene SSX2 and synovial sarcoma.